mifepristone

‌Mifepristone API‌
🌟 USP/EP 98% Purity | Medical Abortion & Cushing’s Syndrome Treatment | cGMP Certified

‌Product Overview‌

Mifepristone is a ‌high-purity active pharmaceutical ingredient (API)‌ primarily used for ‌medical abortion‌ and ‌endocrine disorder management‌. As a ‌progesterone receptor antagonist‌, it effectively blocks hormonal activity, making it critical in ‌reproductive healthcare‌ and ‌Cushing’s syndrome therapy‌. Compliant with ‌USP/EP standards‌, it is widely utilized in ‌pharmaceutical formulations‌ for human therapeutics.

‌Key Benefits‌

✅ ‌98% USP/EP-Grade Purity‌

• Meets stringent pharmacopeial guidelines with ‌HPLC/GC-MS testing‌ (impurities ≤0.2%).

✅ ‌Rapid Therapeutic Action‌

• Achieves peak efficacy within ‌24–48 hours‌ for pregnancy termination.

✅ ‌Stability & Versatility‌

• Compatible with ‌oral tablets‌ and ‌controlled-release formulations‌ (pH 6.0–8.0).

‌Applications‌

      🔹 ‌Reproductive Health‌

• Medical abortion protocols (combined with misoprostol).

• 🔹 ‌Endocrine Disorders‌

• Management of Cushing’s syndrome and hormone-dependent tumors.

‌Quality Certifications‌

📜 ‌USP/EP Monograph Compliance‌

• Produced in ‌FDA/EMA-approved facilities‌ with ISO 9001:2025 accreditation.

📜 ‌cGMP Manufacturing‌

• Rigorous stability testing ensures shelf life of ‌≥24 months‌.

• 
  

‌Market Trends‌

📈 ‌Growing Clinical Demand‌

• Projected ‌9% CAGR growth‌ (2023–2030) driven by rising access to reproductive healthcare.

📈 ‌Research Validation‌

• Cited in ‌20+ clinical trials‌ for efficacy in endocrine and gynecological therapies.